The biopharmaceutical industry is at the forefront of COVID-19 news due to major advances in vaccine development. Now, more than a year since the first case of COVID-19 and nearing a year since daily life has been upended by...more
12/1/2020
/ AstraZeneca ,
Coronavirus/COVID-19 ,
Emergency Use Authorization (EUA) ,
Infectious Diseases ,
Intellectual Property Protection ,
Life Sciences ,
Moderna Inc. ,
Pfizer ,
Public Health ,
Research and Development ,
Vaccinations
SARS-CoV-2, the virus that causes COVID-19, is a novel coronavirus never before seen in humans. To date, it has caused 60,000 deaths in the United States – 56,000 of those in the last month alone. There does not yet exist an...more
For decades, antiviral drugs have been used to combat viral infections, including HIV/AIDS and influenza. Now they are a source of hope in the fight against the COVID-19 pandemic....more
The COVID-19 pandemic has created unprecedented challenges for almost every industry. Most acute is the clinical challenge facing overwhelmed and underequipped hospitals and health care workers....more